Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 674 (LINC00674), also known as CALA (cytoplasmic G3BP1-associated lncRNA), is a spliced multi-exonic long non-coding RNA gene located on human chromosome 17q24.2. It does not encode a protein but plays a key role as a cytoplasmic regulator of gene expression, primarily by scaffolding ribonucleoprotein complexes involving G3BP1, G3BP2, UPF1, and associated NMD factors[2][13]. CALA modulates RNA turnover rates and the efficiency of nonsense-mediated mRNA decay in endothelial cells, thereby affecting cellular homeostasis, migration, and stress responses[2][4][6][10]. Although not a conventional drug target, its biological functions are implicated in endothelial physiology and cancer, making it a subject of ongoing molecular research. There are no known drugs directly interacting with LINC00674, and its clinical therapeutic utility remains unexplored[2][11][13].
Not applicable. No approved or investigational drugs have a defined mechanism of action involving LINC00674
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 674 (LINC00674).